Anebulo Pharmaceuticals, Inc. Quarterly Assets, Current in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Anebulo Pharmaceuticals, Inc. quarterly Assets, Current history and growth rate from Q2 2020 to Q1 2024.
  • Anebulo Pharmaceuticals, Inc. Assets, Current for the quarter ending March 31, 2024 was $5.37M.
Assets, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $5.37M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $6.82M Dec 31, 2023 10-Q 2024-02-13
Q2 2023 $11.7M Jun 30, 2023 10-Q 2024-05-15
Q1 2021 $3.9M Mar 31, 2021 10-Q 2021-06-21
Q2 2020 $3.03M Jun 30, 2020 10-Q 2021-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.